Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Guerin TM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Szabova L; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA. lszabova@mail.nih.gov., Gordon MB; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Lu L; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Pate N; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Sanofi,Global Discovery Pathology, Translational In Vivo Models Platform, Framingham, MA, USA., Bassel L; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Iacovelli AJ; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Genentech, Inc., South San Francisco, CA, USA., Karim B; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Homan PJ; CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Householder DB; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Guerin TM; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Burkett S; Molecular Cytogenetics Core Facility, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Day AM; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Custer W; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA., Weaver Ohler Z; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA. zweaverohler@mail.nih.gov.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2022 Nov 04; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2022 Nov 04.
Autor:
Hagerty B; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., O'Sullivan TN; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Zhang X; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Collins NK; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Custer Lawrence W; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Bassel LL; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Pate N; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Xu J; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Guerin TM; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Kozlov S; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland. alewinecc@mail.nih.gov christine.alewine@nih.gov kozlovse@nci.gov., Alewine C; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. alewinecc@mail.nih.gov christine.alewine@nih.gov kozlovse@nci.gov.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Oct; Vol. 20 (10), pp. 2082-2092. Date of Electronic Publication: 2021 Jul 26.
Autor:
Li D; Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland.; Thoracic & GI Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Schaub N; Surgery Branch, Center for Cancer Research, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.; Leonard Lawson Cancer Center, Pikeville Medical Center, Pikeville, Kentucky., Guerin TM; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland., Bapiro TE; Department of Oncology, University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom.; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Richards FM; Department of Oncology, University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom., Chen V; CCR-SF Bioinformatics Group, Advanced Biomedical and Computational Sciences, Biomedical Informatics and Data Science, Advanced Technology Research Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Talsania K; CCR-SF Bioinformatics Group, Advanced Biomedical and Computational Sciences, Biomedical Informatics and Data Science, Advanced Technology Research Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Kumar P; Sequencing Facility & Single Cell Analysis Facility, Advanced Technology Research Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Gilbert DJ; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland., Schlomer JJ; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland., Kim SJ; GILO Institute, GILO Foundation, Seoul, Korea., Sorber R; Thoracic & GI Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland.; Department of Surgery, The Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland., Teper Y; Thoracic & GI Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland.; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California., Bautista W; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland., Palena C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Ock CY; Department of Hematology & Oncology, Seoul National University Hospital, Seoul, Korea., Jodrell DI; Department of Oncology, University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom., Pate N; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland., Mehta M; Sequencing Facility & Single Cell Analysis Facility, Advanced Technology Research Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Zhao Y; CCR-SF Bioinformatics Group, Advanced Biomedical and Computational Sciences, Biomedical Informatics and Data Science, Advanced Technology Research Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Kozlov S; Center for Advanced Preclinical Research, Frederick National Laboratories for Cancer Research, NCI, Frederick, Maryland. kozlovse@mail.nih.gov rudloffu@mail.nih.gov., Rudloff U; Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland. kozlovse@mail.nih.gov rudloffu@mail.nih.gov.; Thoracic & GI Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland.; Surgery Branch, Center for Cancer Research, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Oct; Vol. 20 (10), pp. 1926-1940. Date of Electronic Publication: 2021 Aug 10.
Autor:
Mukhopadhyay S; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Goswami D; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Adiseshaiah PP; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Burgan W; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yi M; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Guerin TM; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland., Kozlov SV; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland., Nissley DV; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., McCormick F; National Cancer Institute-RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, Maryland. frank.mccormick@ucsf.edu.; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Publikováno v:
Cancer research [Cancer Res] 2020 Apr 15; Vol. 80 (8), pp. 1630-1643. Date of Electronic Publication: 2020 Jan 07.
Autor:
Vilimas T; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Wang AQ; Therapeutics for Rare and Neglected Diseases (TRND) Program, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Patnaik S; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Hughes EA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, 94158, USA., Singleton MD; Biophysics Graduate Group, University of California Berkeley, Berkeley, CA, 94720, USA., Knotts Z; Rare Tumor Initiative (RTI), Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Hatfield Center, 10 Center Drive, 9000 Rockville Pike, Bethesda, MD, 20892, USA., Li D; Rare Tumor Initiative (RTI), Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Hatfield Center, 10 Center Drive, 9000 Rockville Pike, Bethesda, MD, 20892, USA., Frankowski K; Department of Medicinal Chemistry and Specialized Chemistry Center, University of Kansas, Lawrence, KS, USA., Schlomer JJ; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Guerin TM; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Springer S; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Drennan C; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Dextras C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Wang C; Department of Cell and Molecular Biology, Northwestern University, Chicago, IL, 60611, USA., Gilbert D; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Southall N; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Huang S; Department of Cell and Molecular Biology, Northwestern University, Chicago, IL, 60611, USA., Kozlov S; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, 21702, USA., Marugan J; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA. maruganj@mail.nih.gov.; NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bldg B, Rockville, MD, 20850, USA. maruganj@mail.nih.gov., Xu X; Therapeutics for Rare and Neglected Diseases (TRND) Program, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA. xin.xu3@nih.gov., Rudloff U; Rare Tumor Initiative (RTI), Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Hatfield Center, 10 Center Drive, 9000 Rockville Pike, Bethesda, MD, 20892, USA. rudloffu@mail.nih.gov.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Dec; Vol. 82 (6), pp. 1067-1080. Date of Electronic Publication: 2018 Oct 10.
Autor:
Szabova L; Center for Advanced Preclinical Research, Advanced Biomedical Computing Center, SAIC at Frederick National Laboratory for Cancer Research, Mouse Cancer Genetics Program, NCI-Frederick, Frederick, Maryland 21702, USA., Yin C, Bupp S, Guerin TM, Schlomer JJ, Householder DB, Baran ML, Yi M, Song Y, Sun W, McDunn JE, Martin PL, Van Dyke T, Difilippantonio S
Publikováno v:
Cancer research [Cancer Res] 2012 Aug 15; Vol. 72 (16), pp. 4141-53. Date of Electronic Publication: 2012 May 22.